Skip to main content
#
Menu
our twitterour facebook page

Current watchlist:  OTCQB:ILAL  NYSE:GFI  NASD:VLDR   OTC:AABB  NASD:EMBK  OTCQB:BIXT  OTC:GDSI  OTCQB:MITI

Bioxytran, Inc. Announces the Reinitiation of Coverage of Its Stock by Avise AnalyticsPress Release | 11/22/2022

BOSTON, MASSACHUSETTS, Nov. 22, 2022 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT), a clinical stage biotechnology company developing novel therapies targeting the treatment of significant unmet medical needs in virology, degenerative disease, and hypoxia, announces the reinitiation of coverage of its stock by Avise Analytics, a leading equity research firm specializing in micro-cap and small-cap public companies research, giving a fair valuation of $2.71 per share.

The full research report is available here

Smallcap Stocks, Small Cap Stocks, Micro Cap Stocks, Nasdaq Stocks, NYSE stocks, OTC PINK SHEET STOCKS, OTC MARKET, OTCQB, Stock picks, Investor research, 
Day Trading, Day Traders, Stock Picks, Stock Picks

    our twitterour facebook page
    Small Cap Corner

    Spotlighting Small Cap companies with solid foundations and long term potential.